We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
Cap. Flow
-$238M
Cap. Flow %
-4.58%
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$38.2M
2
CCL icon
Carnival Corporation Ltd
CCL
+$37.7M
3
WBA
Walgreens Boots Alliance
WBA
+$35.3M
4
ICLR icon
Icon
ICLR
+$30.9M
5
CELG
Celgene Corp
CELG
+$29.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.8M
2
DHR icon
Danaher
DHR
+$50.4M
3
AZO icon
AutoZone
AZO
+$36.8M
4
AGN
Allergan plc
AGN
+$33.9M
5
BIIB icon
Biogen
BIIB
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Healthcare 24.38%
3 Financials 20.66%
4 Communication Services 10.61%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNG icon
201
RingCentral
RNG
$4.05B
$2.46M 0.05%
132,787
-82,621
-38% -$1.44M
SUPN icon
202
Supernus Pharmaceuticals
SUPN
$2.68B
$2.4M 0.05%
141,074
+29,401
+26% +$418K
ICPT
203
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.37M 0.05%
9,828
+453
+5% +$121K
AXON
204
Axon Enterprise
AXON
$40.5B
$2.16M 0.04%
64,927
-78,474
-55% -$2.45M
AGU
205
DELISTED
Agrium
AGU
$2.15M 0.04%
20,300
-18,300
-47% -$1.93M
IPGP icon
206
IPG Photonics
IPGP
$3.89B
$2.13M 0.04%
+25,000
New +$2.35M
MPT
207
Medical Properties Trust
MPT
$2.89B
$2.12M 0.04%
161,870
-95,000
-37% -$1.32M
ACOR
208
DELISTED
Acorda Therapeutics
ACOR
$1.78M 0.03%
445
+381
+595% +$1.47M
MTLS
209
Materialise
MTLS
$379M
$1.78M 0.03%
196,108
-30,321
-13% -$235K
KEYW
210
DELISTED
The KEYW Holding Corporation
KEYW
$1.78M 0.03%
+190,602
New +$1.7M
DHC
211
Diversified Healthcare Trust
DHC
$2.26B
$1.75M 0.03%
100,900
+20,180
+25% +$400K
TWO
212
Two Harbors Investment
TWO
$1.27B
$1.75M 0.03%
22,500
– –
MBLY
213
DELISTED
Mobileye N.V.
MBLY
$1.74M 0.03%
32,683
-37,380
-53% -$1.77M
TU icon
214
Telus
TU
$16B
$1.73M 0.03%
90,000
– –
OHI icon
215
Omega Healthcare
OHI
$15.4B
$1.72M 0.03%
50,000
– –
MDVN
216
DELISTED
MEDIVATION, INC.
MDVN
$1.71M 0.03%
29,852
-396
-1% -$24.4K
WELL icon
217
Welltower
WELL
$178B
$1.64M 0.03%
25,000
– –
BMRN icon
218
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.63M 0.03%
11,903
+1,940
+19% +$240K
APIC
219
DELISTED
Apigee Corporation Common Stock
APIC
$1.63M 0.03%
+164,770
New +$2.26M
NVDQ
220
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.57M 0.03%
130,000
– –
NHI icon
221
National Health Investors
NHI
$3.9B
$1.56M 0.03%
25,000
– –
CVS icon
222
CVS Health
CVS
$137B
$1.52M 0.03%
14,500
+500
+4% +$51.1K
DATA
223
DELISTED
Tableau Software, Inc.
DATA
$1.48M 0.03%
12,794
-62,342
-83% -$6.74M
KMI icon
224
Kinder Morgan
KMI
$73.1B
$1.44M 0.03%
37,500
– –
HR
225
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.39M 0.03%
60,000
– –
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.

  • Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
  • Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
  • Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
  • Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
  • Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
  • Polar Capital opened 43 new positions and closed 61 in Q2 2015.
  • Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.